Help us to help!
LUNIRI is a non-profit organization. We are developing a new therapeutic approach to treat lupus nephritis, a potentially fatal involvement of the kidneys in the context of the autoimmune disease systemic lupus erythematosus (SLE). Our current studies show promising results but we need further funding. This is the main purpose of this website: To kindly ask for your help.
In conclusion, our data provide evidence that irinotecan might represent an entirely new strategy for the treatment of systemic lupus erythematosus.
If our planned clinical study is successful there are good chances of:
- getting approval for an entirely new treatment option for patients with refractory lupus nephritis
- improving the quality of life and the survival of patients with lupus nephritis
- further developing a targeted treatment for lupus nephritis with reduced or no side effects experienced with conventional SLE medication
- potentially introducing a new treatment option for patients with less severe SLE
To countinue our efforts and to advance our research we rely on your help.
Our previous research as seen in